OBJECTIVES The purpose of this study was to determine the efficacy and safety of radial versus femoral access in women undergoing coronary angiography/intervention. BACKGROUND The risk of bleeding and vascular access site complications are higher in women than in men.
O ver the past 5 years, there has been an increase in the uptake of radial access for percutaneous coronary intervention (PCI) for both elective and emergency cases in Europe and North America (1) (2) (3) . The RIVAL (RadIal Vs femorAL access for coronary intervention) trial randomized 7,021 patients with acute coronary syndrome to either radial or femoral access for coronary angiography and PCI and showed that, overall, there was no difference in the primary composite outcome of death, myocardial infarction (MI), stroke, or non-coronary artery bypass graft (CABG) bleeding, with a significant reduction in major vascular complications (4) .
Observational data suggest that female sex is an independent risk factor for major bleeding and that the use of radial access for PCI likely reduces this risk (5, 6) . However, there are concerns that radial access may be technically more challenging in women due to smaller radial arteries and increased rates of radial artery spasm, potentially leading to lower procedural success rates. Most randomized trials comparing radial with femoral access have enrolled more men than women, making data regarding radial access specific to women very pertinent (7) .
We sought to determine the efficacy and safety of radial versus femoral access in women and men in this pre-specified subgroup analysis.
METHODS
RIVAL was a randomized, parallel-group, multicenter trial. Patients with acute coronary syndromes, with or without ST-segment elevation, and planned for invasive therapy were included. Patients with cardiogenic shock, severe peripheral arterial disease precluding femoral approach, previous coronary bypass surgery with use of more than 1 internal mammary artery, and a negative Allen's test (absence of dual circulation of hand) were ineligible for inclusion. The study was approved by all appropriate national regulatory authorities and ethics committees of participating centers, and participants provided written informed consent prior to enrollment. The primary efficacy outcome was a composite of death, MI, stroke, or non-CABG major bleeding at 30 days. Other outcomes included composite of death, MI, or stroke; components of primary outcome; major vascular complications; access site pain; crossover rates; PCI success and complication rates; procedure duration; contrast volumes used; and patient preference for next procedure.
Major vascular complications included retroperitoneal hematoma, pseudoaneurysm requiring ultrasound compression, thrombin injection or surgical repair, large hematomas requiring prolonged hospitalization, arteriovenous fistulae, limb ischemia or damage to adjacent nerve, and other surgical access site repair. RIVAL major bleeding was defined as bleeding that was fatal; resulted in transfusion of $2 U red blood cells; caused significant hypotension requiring inotropes; required surgical intervention; caused severe disabling sequelae; was intracranial or intraocular; or led to a drop in hemoglobin of at least 50 g/l. ACUITY (Acute Catheterization and Urgent Intervention strategy) non-CABG-related major bleeding was defined as RIVAL major bleeding, large hematomas, and pseudoaneurysms requiring intervention (4). Table 1 shows baseline characteristics and procedural characteristics of the study population. It illustrates that both female and male subgroups allocated to radial versus femoral access were well matched in terms of demographics, background medical history, and type of acute coronary syndrome presentation. However, GP IIb/IIIa inhibitor usage was greater in the male subgroup. In terms of procedural differences, 5-F catheters were used more frequently with radial access (women 18.6%; men 12.9%) than femoral access (women 9.3%; men 
Insights From the RIVAL Trial 5.7%), and catheters size $7-F were used more frequently with femoral access (women 3.9%; men 6.8%) than radial access (women 0.7%; men 1.0%). Values are n/N (%), mean AE SD, or median (quartile 1-quartile 3). *Primary efficacy outcome: composite of death, MI, stroke, or non-CABG bleeding. †PCI complications: coronary dissection with reduced flow, abrupt closure, no reflow, coronary perforation, and stent thrombosis (definite and probable).
ACUITY ¼ Acute Catheterization and Urgent Intervention strategy; CI ¼ confidence interval; HR ¼ hazard ratio; other abbreviations as in Table 1 .
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In terms of absolute benefit for major vascular complications, among women, the absolute risk reduction Crossover rates from radial to femoral access were higher than femoral to radial in both groups (women:
11.1% vs. Table 2) . PCI complications (such as coronary dissection, abrupt closure, no reflow, coronary perforation, and catheter or stent thrombosis) were also unrelated to route of access in both female and male patients.
Compared with patients who had femoral access, major vascular complications were reduced among both women and men who had radial access, irrespective of whether PCI was performed ( Table 3) .
A significant portion (86.1%) of the female patients who had radial access noted that they would prefer repeat radial access. Only 50.1% of patients who had femoral access noted that they would prefer repeat femoral access (p < 0.001).
Overall, the rates of major vascular complications were higher in women than in men (4.7% vs. 1.7%; p < 0.0001). Multivariable analyses were performed to assess for possible predictors of major vascular complications and radial-to-femoral access site crossover. The interaction p was nonsignificant (0.07). The absolute risk reduction (ARR) for radial access versus femoral access in women was 3.0%, compared with 2.0% in men. NNT ¼ number needed to treat.
FIGURE 2 Major Reasons for Access Site Crossover From Radial to Femoral in Women and Men
There was a significant difference in the rates of crossover due to radial artery spasm (9.5% vs. 3.3%; p < 0.001) and radial artery loops (2.5% vs. 0.8%; p ¼ 0.006) in women versus men.
Pandie et al. In terms of patient preference for subsequent procedures, both women and men would prefer radial access. This is important because despite Values are n (%). *Primary efficacy outcome: composite of death, MI, stroke, or non-CABG bleeding.
Abbreviations as in Tables 1 and 2 .
FIGURE 3 Predictors of Major Vascular Complications
Significant predictors of major vascular complications as assessed by multivariable analysis.
These include women, older age (per 10 years), patients undergoing percutaneous coronary intervention (PCI), and the use of glycoprotein (GP) IIb/IIIa inhibitors.
CI ¼ confidence interval.
Insights From the RIVAL Trial Even though women versus men was a pre-defined subgroup, the RIVAL trial randomization was not powered to assess differences between sexes, and randomization was not stratified by sex.
Female sex is a subgroup analysis and so should be considered hypothesis generating. However, the results of our subgroup are consistent with an independent randomized trial performed in women.
CONCLUSIONS
Women undergoing coronary angiography and PCI are at higher risk of vascular complications compared with men. Radial access is an effective method to reduce these vascular complications.
